ÀÚ°¡¸é¿ªÁúȯ ȯÀÚÀÇ µçµçÇÑ µ¿¹ÝÀÚ
| Á¦ ¸ñ | Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Predicting Imaging Remission in Rheumatoid Arthritis: a Case-control Ultrasound Study |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Àü½ÅÈ«¹Ý·çǪ½ºÀÇ »õ·Î¿î ºÐ·ù ±âÁØ |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Concurrent treatment with rituximab and plasma exchange for severe refractory granulomatosis with polyangiitis: A case report |
|---|---|
| ¹ßÇ¥³âµµ | 2019 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | A systemic lupus erythematosus patient with thunderclap headache: reversible cerebral vasoconstriction syndrome |
|---|---|
| ¹ßÇ¥³âµµ | 2019 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Potential Therapeutic Antibodies Targeting Specific Adiponectin Isoforms in Rheumatoid Arthritis |
|---|---|
| ¹ßÇ¥³âµµ | 2018 |
| ¹ßÇ¥Áö |

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.
¼¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø